Chemical and Pharmaceutical Bulletin p. 2362 - 2369 (1992)
Update date:2022-08-02
Topics:
Sakoda
Kamikawaji
Seto
The effect of the 3-carboxylic-ester variation in 2,2-dimethyltrimethylene 3-alkoxycarbonyl-4-aryl-1,4-dihydro-2,6-dimethyl-5-pyridinephosphonate s (1) was investigated with relation to the calcium-antagonistic and antihypertensive activities: the analogs containing the alkyl groups of not more than 12 carbons and an amino functionality in the carboxylic-ester moiety were synthesized to be examined for biological activities. Among them, 2-[benzyl(phenyl)amino]-ethyl 5-(5,5-dimethyl-2-oxo-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-di methyl-4-(3-nitrophenyl)-3-pyridine-carboxylate hydrochloride ethanol (NZ-105) showed particularly beneficial activities and was selected for further pharmacological studies and clinical development. Some aspects of the structure-activity relationships and solid-state structure of NZ-105 by X-ray crystallographic analysis were described.
View MoreContact:
Address:
ClickChem Technology Co., Limited
Contact:+86-0310-6519966/0531-52893837
Address:No.750 Shunhua Road, High-Tech Zone, Jinan city, Shandong China
Angelisun(Chongqing) Pharmaceutical Co., LTD.
Contact:+86-23-68030926-816
Address:D1-7 Tech & Entrepreneurs Park, Kecheng Road, Erlang Hi-Tech Areas, Chongqing, China
Tianjin Te-An Chemtech Co., Ltd.
Contact:+86-22-65378638
Address:A5-8, No.80 Haiyun Street, TEDA
Contact:+1-973-357-0577
Address:10 Taft Rd.
Doi:10.1055/s-0029-1218372
(2009)Doi:10.1016/S0040-4020(01)89790-8
(1988)Doi:10.1002/chem.200901842
(2010)Doi:10.1007/BF00475685
(1988)Doi:10.1055/s-1988-27729
(1988)Doi:10.1246/cl.2010.24
(2010)